On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1360 AM Northeast, WI 97.5 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
64° Feels Like: 64°
Wind: SSW 8 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 59°

Tomorrow

PM Thunderstorms 76°

Sat Night

Scattered Thunderstorms 65°

Alerts

FDA declines to approve Durect's pain drug

(Reuters) - U.S. Food and Drug Administration declined to approve Durect Corp's post-operative pain treatment, saying the application lacked enough data to prove the drug was safe.

Durect's shares fell about 30 percent after the bell.

The FDA indicated that more clinical safety studies would have to be conducted on the drug, Posidur, Durect said.

The specialty pharmaceutical company said it was evaluating the issues described in the "complete response letter", the type of letter issued by the FDA to convey that it cannot approve a drug application in its current form.

Durect's shares closed at $1.95 Wednesday on the Nasdaq.

(Reporting by Shailesh Kuber; Editing by Don Sebastian)

Comments